X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2169) 2169
science & technology (1820) 1820
life sciences & biomedicine (1802) 1802
male (1542) 1542
female (1411) 1411
urinary bladder neoplasms - surgery (1309) 1309
aged (1280) 1280
urology & nephrology (1209) 1209
middle aged (1193) 1193
cystectomy (1183) 1183
cystectomy - adverse effects (949) 949
bladder cancer (813) 813
cystectomy - methods (775) 775
treatment outcome (754) 754
urinary bladder neoplasms - pathology (658) 658
adult (635) 635
retrospective studies (562) 562
urology (554) 554
aged, 80 and over (502) 502
oncology (465) 465
radical cystectomy (426) 426
urinary bladder neoplasms - mortality (397) 397
cancer (376) 376
urinary diversion - adverse effects (371) 371
risk factors (361) 361
follow-up studies (358) 358
carcinoma, transitional cell - surgery (341) 341
surgery (339) 339
time factors (322) 322
neoplasm staging (303) 303
analysis (285) 285
urinary diversion (285) 285
care and treatment (279) 279
abridged index medicus (277) 277
prognosis (277) 277
urinary diversion - methods (256) 256
neoplasm invasiveness (250) 250
urinary bladder neoplasms - drug therapy (244) 244
urinary bladder neoplasms - therapy (221) 221
postoperative complications - etiology (211) 211
chemotherapy (210) 210
medicine & public health (204) 204
carcinoma, transitional cell - pathology (195) 195
urinary bladder - surgery (189) 189
survival rate (188) 188
prospective studies (187) 187
health aspects (186) 186
postoperative complications - epidemiology (184) 184
disease-free survival (180) 180
mortality (168) 168
combined modality therapy (161) 161
cystectomy - mortality (159) 159
chemotherapy, adjuvant (156) 156
postoperative complications (156) 156
research (154) 154
patient outcomes (153) 153
quality of life (153) 153
complications (152) 152
risk assessment (147) 147
bladder (144) 144
kaplan-meier estimate (137) 137
carcinoma, transitional cell - mortality (135) 135
antineoplastic combined chemotherapy protocols - therapeutic use (133) 133
urinary bladder neoplasms (131) 131
urinary reservoirs, continent - adverse effects (129) 129
survival (127) 127
ileum - surgery (122) 122
laparoscopy (122) 122
multivariate analysis (117) 117
survival analysis (112) 112
nephrology (109) 109
proportional hazards models (109) 109
administration, intravesical (108) 108
urothelial carcinoma (108) 108
laparoscopy - adverse effects (105) 105
length of stay (104) 104
complications and side effects (101) 101
prostatectomy - adverse effects (99) 99
patients (98) 98
urinary bladder - pathology (98) 98
urinary bladder neoplasms - radiotherapy (96) 96
recurrence (95) 95
lymphatic metastasis (93) 93
robotic surgery (93) 93
age factors (92) 92
usage (92) 92
carcinoma, transitional cell - drug therapy (91) 91
urinary reservoirs, continent (91) 91
disease progression (90) 90
incidence (90) 90
tumors (90) 90
neoplasm recurrence, local (89) 89
radiotherapy (89) 89
cisplatin - administration & dosage (88) 88
medical colleges (86) 86
urinary incontinence - etiology (85) 85
urinary bladder (84) 84
obstetrics & gynecology (83) 83
lymph node excision (82) 82
antineoplastic combined chemotherapy protocols - adverse effects (80) 80
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2245) 2245
French (67) 67
German (40) 40
Japanese (37) 37
Spanish (35) 35
Italian (22) 22
Portuguese (16) 16
Chinese (15) 15
Russian (14) 14
Danish (4) 4
Serbian (3) 3
Croatian (2) 2
Turkish (2) 2
Bosnian (1) 1
Czech (1) 1
Dutch (1) 1
Finnish (1) 1
Norwegian (1) 1
Polish (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 02/2016, Volume 54, pp. 69 - 74
Abstract Background There is continuing controversy regarding the optimal regimen for neoadjuvant chemotherapy (NAC) in bladder cancer. Patients and methods We... 
Hematology, Oncology and Palliative Medicine | Neoadjuvant chemotherapy | Dose intensity | Muscle-invasive disease | Transitional cell carcinoma | Urothelial carcinoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Urothelium - pathology | Cisplatin - administration & dosage | Neoadjuvant Therapy - mortality | Time Factors | Vinblastine - adverse effects | Urinary Bladder Neoplasms - pathology | Female | Retrospective Studies | Chemotherapy, Adjuvant | France | Doxorubicin - administration & dosage | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Methotrexate - adverse effects | Cystectomy | Neoadjuvant Therapy - adverse effects | Cisplatin - adverse effects | Methotrexate - administration & dosage | Aged | Neoplasm Staging | Urothelium - drug effects | Doxorubicin - adverse effects | Anthracyclines | Adjuvant treatment | Methotrexate | Bladder cancer | Standards | Biometry | Cancer | Analysis | Index Medicus | Life Sciences
Journal Article
European urology, ISSN 0302-2838, 06/2011, Volume 59, Issue 6, pp. 997 - 1008
Journal Article
Journal Article
Journal Article
European urology, ISSN 0302-2838, 2011, Volume 59, Issue 6, pp. 1009 - 1018
Journal Article